Olema Pharmaceuticals, Inc. (OLMA)
↓ Download CSVKey ratios (FY2025)
-33.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -$178.70M | -$142.26M | -$104.96M | -$106.99M | -$71.49M | -$21.53M | -$4.32M | — |
| Net Income | -$162.45M | -$129.47M | -$96.66M | -$104.79M | -$71.10M | -$22.12M | -$4.32M | — |
| EPS (Diluted) | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 | $-3.42 | $-1.66 | — |
| Total Assets | $533.43M | $450.98M | $276.94M | $215.65M | $295.94M | $342.72M | — | — |
| Total Liabilities | $54.87M | $42.02M | $23.05M | $18.10M | $11.38M | $4.58M | — | — |
| Shareholders' Equity | $478.56M | $408.96M | $253.90M | $197.55M | $284.57M | $338.14M | -$10.59M | -$8.40M |
| Cash & Equivalents | $48.30M | $139.48M | $68.54M | $23.70M | $13.81M | $338.55M | — | — |
| Operating Cash Flow | -$146.72M | -$104.35M | -$83.73M | -$82.06M | -$50.69M | -$19.87M | -$3.08M | — |
| Capital Expenditures | — | $159.0K | — | $363.0K | $1.57M | $56.0K | — | — |
| Shares Outstanding | 87.01M | 58.74M | 45.25M | 40.00M | 39.52M | 7.02M | 2.59M | — |